Click to Skip Ad
Closing in...
Regeneron News

FDA just authorized another breakthrough coronavirus drug

The FDA approved another monoclonal antibody drug for coronavirus therapy — this time it’s Regeneron’s dual antibody cocktail. Casirivimab and imdevimab received an Emergency Use Authorization for the treatment of mild to moderate >>